| 摘要 |
The present invention is related to a use of a marker gene or a gene product thereof or a combination of marker genes or a combination of the gene products thereof, wherein the marker gene(s) is/are selected from the group comprising SLC1A7, SLC1A2, TF, GRIK4, CNR2, IGF-1R, CHAK2, GRINL1A, CHRNA1, GSTM1, FTH1, NDUFS3, LYST, SYNII, COG2, PEX5, STX5A, HIST1H3E, IRS4, RPL36A, GFAP, IDE and DEFA1; as a peripheral marker for diagnosing a neurodegenerative disease. |
